Cyril O Anyadike, MD
Gastroenterology · Los Angeles
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- Not verified
- Not the same as out of network.
- Office
- 1
- Since medical school
- 30 years
- Wake Forest University School of Medicine, 1996
Offices
1 location · West Gastroenterology Medical Group · 4 clinicians in this group
Looking this up.
Plan participation
Not verified
We could not verify current plan participation for this doctor. This does not mean they are out of network. Call Dr. Anyadike’s office at (310) 674-0144 to ask if they take your plan before you enroll.
California Medical Board record
Licence A78604 · Current
Licensed to practise in California · since 2002 · expires 2028-04-30 · Bowman Gray School of Medicine of Wake Forest University.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Surgery centers they own
- Conejo Valley Outpatient Center, LLCAmbulatory Surgery Center · Los Angeles, CA25% owner since 2015 · accredited by AAAASFCanceled3 inspections, 3 with deficiencies · last 2015-11-18: Requirements Met
- Health Point Los Angeles Surgery Center, LLCOffice-Based Surgery Center · Newbury Park, CA25% owner since 2015 · accredited by AAAASFDenied AccreditationNo inspections published
- LB Surgical Center LLCOffice-Based Surgery Center · Long Beach, CA33% owner since 2016 · accredited by AAAASFAccreditation Renewed3 inspections, 2 with deficiencies · last 2019-11-05: Requirements Met
- LB Surgical Center, LLCAmbulatory Surgery Center · Long Beach, CA25% owner since 2016 · accredited by AAAASFInitial AccreditationNo inspections published
- The Los Angeles/Inglewood Endoscopy ASC, L.P.Ambulatory Surgery Center · Los Angeles, CA12.3% owner since 2000 · accredited by AAAHCAccreditation Renewed6 inspections, 2 with deficiencies · last 2024-10-30: Requirements Met
School, training and certification
What this clinician told their state board, medical school and everything before it. Only some states publish this, so nothing here means the state does not say, not that there was no training or certification.
Specialty certification
- American Board of Internal Medicine - Gastroenterology
Original Medicare doctor bills
$34,829
Medicare paid this office $34,829 for 211 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Return visit (30+ min) | 117 | $14,161 | $96 |
| New patient visit (45+ min) | 48 | $5,192 | $108 |
| Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | 18 | $3,197 | $178 |
| Biopsy of large bowel using a flexible endoscope | 21 | $2,899 | $138 |
| Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 34 | $2,770 | $81 |
See all 7 services
| Return visit (30+ min) | 117 | $14,161 | $96 |
| New patient visit (45+ min) | 48 | $5,192 | $108 |
| Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | 18 | $3,197 | $178 |
| Biopsy of large bowel using a flexible endoscope | 21 | $2,899 | $138 |
| Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 34 | $2,770 | $81 |
| Removal of polyps or growths of large bowel using an endoscope with mechanical snare | 13 | $2,569 | $198 |
| Moderate sedation services provided by the same physician or other qualified health care professional performing a gastrointestinal endoscopic service that sedation supports, requiring the presence of an independent trained observer to assist in the monito | 83 | $336 | $4 |
Procedures Medicare counted
| Colonoscopy | 68 | More than 70% of doctors who do this |
| Upper gastrointestinal (GI) endoscopy for acid reflux | 45 | More than 62% of doctors who do this |
Procedures year by year
| Procedure | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|
| Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 64 | 47 | 29 | 50 | 32 | 34 |
| Biopsy of large bowel using a flexible endoscope | 54 | 36 | 30 | 34 | 30 | 21 |
| Removal of polyps or growths of large bowel using an endoscope with mechanical snare | 21 | – | 16 | – | 13 | 13 |
| Diagnostic exam of large bowel using a flexible endoscope | – | – | 12 | – | – | – |
Times billed to Original Medicare each year. A blank year means fewer than 11 people had it, or none: Medicare does not publish smaller counts. Medicare Advantage patients are not included.
Who their Medicare patients are
211 Original Medicare patients in 2024. Average age 67 · Under 65 25% · Women 63% · Also on Medicaid 80% · Health risk score 1.35. At or below the middle of the specialty; the typical gastroenterology clinician is at 1.42.
Conditions among them: High blood pressure 74% · Diabetes 44% · Depression 22% · Coronary heart disease 21% · Chronic kidney disease 18% · COPD 15% · Cancer 14% · Heart failure 13% · Stroke 8% · Dementia 7% · Atrial fibrillation 6%.
The office billed $175,042, Medicare allowed $47,527 and paid $34,829; for 390 services of 15 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 211 | 390 | 67 | 1.35 | $175,042 | $34,829 |
| 2023 | 249 | 459 | 67 | 1.25 | $200,365 | $41,313 |
| 2022 | 261 | 488 | 68 | 1.43 | $212,618 | $42,007 |
| 2021 | 271 | 503 | 67 | 1.29 | $229,037 | $48,342 |
| 2020 | 211 | 407 | 67 | 1.40 | $194,243 | $37,163 |
| 2019 | 336 | 657 | 69 | 1.48 | $301,262 | $54,337 |
| 2018 | 323 | 577 | 69 | 1.51 | $263,981 | $47,679 |
| 2017 | 371 | 815 | 68 | 1.55 | $339,670 | $60,461 |
| 2016 | 362 | 547 | 68 | 1.60 | $321,009 | $61,076 |
| 2015 | 453 | 698 | 71 | 2.19 | $453,085 | $87,624 |
| 2014 | 465 | 713 | 73 | 2.26 | $495,298 | $87,209 |
| 2013 | 805 | 1,255 | 71 | 2.63 | $872,625 | $162,502 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 7 services
| Return visit (30+ min) | 151 | $18,461 | $99 |
| New patient visit (45+ min) | 55 | $6,397 | $116 |
| Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | 21 | $3,915 | $186 |
| Biopsy of large bowel using a flexible endoscope | 30 | $3,323 | $111 |
| Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 32 | $2,855 | $89 |
| Removal of polyps or growths of large bowel using an endoscope with mechanical snare | 13 | $2,603 | $200 |
| Moderate sedation services provided by the same physician or other qualified health care professional performing a gastrointestinal endoscopic service that sedation supports, requiring the presence of an independent trained observer to assist in the monito | 91 | $365 | $4 |
2022: 8 services
| Return visit (30+ min) | 94 | $10,103 | $96 |
| Biopsy of large bowel using a flexible endoscope | 33 | $4,937 | $145 |
| Short return visit (20+ min) | 65 | $4,714 | $67 |
| New patient visit (45+ min) | 37 | $4,602 | $124 |
| Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 50 | $4,584 | $92 |
| Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | 20 | $3,571 | $179 |
| New patient visit (30+ min) | 24 | $2,312 | $96 |
| Moderate sedation services provided by the same physician or other qualified health care professional performing a gastrointestinal endoscopic service that sedation supports, requiring the presence of an independent trained observer to assist in the monito | 105 | $451 | $4 |
2021: 10 services
| Return visit (30+ min) | 105 | $12,745 | $105 |
| Short return visit (20+ min) | 72 | $6,285 | $78 |
| New patient visit (45+ min) | 46 | $5,917 | $129 |
| Biopsy of large bowel using a flexible endoscope | 30 | $4,016 | $134 |
| Removal of polyps or growths of large bowel using an endoscope with mechanical snare | 16 | $3,500 | $219 |
| New patient visit (30+ min) | 36 | $3,483 | $97 |
| Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | 18 | $3,208 | $178 |
| Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 29 | $2,694 | $93 |
| Diagnostic exam of large bowel using a flexible endoscope | 12 | $1,866 | $155 |
| Moderate sedation services provided by the same physician or other qualified health care professional performing a gastrointestinal endoscopic service that sedation supports, requiring the presence of an independent trained observer to assist in the monito | 88 | $381 | $4 |
2020: 6 services
| Return visit (30+ min) | 97 | $10,765 | $93 |
| New patient visit (45+ min) | 48 | $6,522 | $136 |
| Biopsy of large bowel using a flexible endoscope | 36 | $5,282 | $147 |
| Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 47 | $4,893 | $104 |
| Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | 15 | $2,951 | $197 |
| Moderate sedation services provided by the same physician or other qualified health care professional performing a gastrointestinal endoscopic service that sedation supports, requiring the presence of an independent trained observer to assist in the monito | 102 | $469 | $4 |
2019: 9 services
| Return visit (30+ min) | 119 | $11,209 | $86 |
| New patient visit (45+ min) | 65 | $8,436 | $130 |
| Biopsy of large bowel using a flexible endoscope | 54 | $7,258 | $134 |
| Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 62 | $7,179 | $112 |
| Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | 27 | $5,204 | $193 |
| Short return visit (20+ min) | 70 | $4,671 | $60 |
| Removal of polyps or growths of large bowel using an endoscope with mechanical snare | 21 | $4,313 | $205 |
| New patient visit (30+ min) | 19 | $1,528 | $80 |
| Moderate sedation services provided by the same physician or other qualified health care professional performing a gastrointestinal endoscopic service that sedation supports, requiring the presence of an independent trained observer to assist in the monito | 165 | $711 | $4 |
2018: 9 services
| Return visit (30+ min) | 176 | $17,026 | $78 |
| New patient visit (45+ min) | 99 | $10,861 | $110 |
| Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 48 | $4,389 | $91 |
| Biopsy of large bowel using a flexible endoscope | 25 | $3,598 | $144 |
| Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | 14 | $2,568 | $183 |
| Colorectal cancer screening; colonoscopy on individual at high risk | 14 | $2,506 | $179 |
| Removal of polyps or growths of large bowel using an endoscope with mechanical snare | 11 | $2,343 | $213 |
| Moderate sedation services provided by the same physician or other qualified health care professional performing a gastrointestinal endoscopic service that sedation supports, requiring the presence of an independent trained observer to assist in the monito | 90 | $387 | $4 |
| Use of a drug to induce depression of consciousness by physician performing a procedure, each additional 15 minutes | 16 | $151 | $9 |
2017: 12 services
| Return visit (30+ min) | 157 | $14,179 | $79 |
| Biopsy of large bowel using a flexible endoscope | 65 | $8,890 | $137 |
| Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | 46 | $8,663 | $188 |
| New patient visit (45+ min) | 64 | $7,162 | $112 |
| Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 72 | $6,067 | $84 |
| Removal of polyps or growths of large bowel using an endoscope with mechanical snare | 14 | $3,017 | $215 |
| Colorectal cancer screening; colonoscopy on individual at high risk | 11 | $2,244 | $187 |
| Short return visit (20+ min) | 24 | $1,262 | $50 |
| Use of a drug to induce depression of consciousness by physician performing a procedure, each additional 15 minutes | 119 | $1,059 | $9 |
| New patient visit (30+ min) | 13 | $1,008 | $78 |
| Moderate sedation services provided by the same physician or other qualified health care professional performing a gastrointestinal endoscopic service that sedation supports, requiring the presence of an independent trained observer to assist in the monito | 153 | $629 | $4 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 12 | $101 | $8 |
2016: 10 services
| Return visit (30+ min) | 107 | $10,426 | $83 |
| Biopsy of large bowel using a flexible endoscope | 66 | $8,873 | $134 |
| Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 89 | $7,924 | $88 |
| Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | 40 | $7,894 | $197 |
| Removal of polyps or growths of large bowel using an endoscope with mechanical snare | 27 | $5,870 | $217 |
| New patient visit (45+ min) | 43 | $5,616 | $131 |
| Short return visit (20+ min) | 53 | $2,901 | $50 |
| Diagnostic exam of large bowel using a flexible endoscope | 19 | $2,763 | $145 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 16 | $1,818 | $114 |
| New patient visit (30+ min) | 25 | $1,669 | $67 |
2015: 12 services
| Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 138 | $13,532 | $94 |
| Biopsy of large bowel using a flexible endoscope | 67 | $13,015 | $191 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 72 | $12,185 | $169 |
| Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | 42 | $9,173 | $218 |
| Diagnostic exam of large bowel using a flexible endoscope | 47 | $7,907 | $168 |
| Removal of polyps or growths of large bowel using an endoscope with mechanical snare | 23 | $5,891 | $256 |
| Short return visit (20+ min) | 89 | $5,658 | $55 |
| New patient visit (30+ min) | 59 | $4,622 | $78 |
| Return visit (30+ min) | 36 | $3,662 | $87 |
| Insertion of stomach tube using a flexible endoscope | 18 | $3,098 | $172 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 24 | $2,347 | $87 |
| New patient visit (45+ min) | 16 | $2,140 | $134 |
2014: 14 services
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 80 | $13,203 | $165 |
| Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 102 | $10,866 | $103 |
| Insertion of stomach tube using a flexible endoscope | 45 | $8,329 | $177 |
| Biopsy of large bowel using a flexible endoscope | 42 | $7,960 | $190 |
| Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | 33 | $7,444 | $226 |
| Diagnostic exam of large bowel using a flexible endoscope | 40 | $6,610 | $165 |
| Removal of polyps or growths of large bowel using an endoscope with mechanical snare | 20 | $5,014 | $251 |
| Short return visit (20+ min) | 56 | $3,996 | $59 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 39 | $3,554 | $85 |
| New patient visit (30+ min) | 42 | $3,532 | $84 |
| Long return visit (40+ min) | 22 | $2,563 | $116 |
| Subsequent hospital care with straightforward or low level of medical decision making, per day at least 25 minutes | 55 | $2,465 | $32 |
| Return visit (30+ min) | 25 | $2,061 | $76 |
| Diagnostic exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 16 | $1,397 | $82 |
2013: 18 services
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 201 | $32,640 | $162 |
| Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 208 | $24,464 | $116 |
| Insertion of stomach tube using a flexible endoscope | 73 | $15,910 | $207 |
| Biopsy of large bowel using a flexible endoscope | 67 | $13,157 | $196 |
| Diagnostic exam of large bowel using a flexible endoscope | 70 | $11,269 | $159 |
| Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | 44 | $9,822 | $223 |
| Removal of polyps or growths of large bowel using an endoscope with mechanical snare | 28 | $7,089 | $253 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 71 | $6,689 | $84 |
| Subsequent hospital care with straightforward or low level of medical decision making, per day at least 25 minutes | 121 | $5,113 | $32 |
| Return visit (30+ min) | 63 | $4,614 | $63 |
| Colorectal cancer screening; colonoscopy on individual at high risk | 20 | $4,468 | $223 |
| Diagnostic exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 33 | $3,579 | $105 |
| Long return visit (40+ min) | 30 | $3,445 | $108 |
| New patient visit (45+ min) | 19 | $2,208 | $116 |
| New patient visit (30+ min) | 24 | $1,803 | $75 |
| Incision of pancreatic outlet using a flexible endoscope | 12 | $1,222 | $102 |
| Short return visit (20+ min) | 16 | $1,061 | $59 |
| Change of stomach feeding, accessed through the skin | 15 | $589 | $39 |
Medicaid work
$285,458 in 2024
Medicaid paid $285,458 for 4,146 billed services this clinician did in 2024, up to 147 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| DIAGNOSTIC COLONOSCOPY | 337 | $65,590 |
| Upper gastrointestinal endoscopy with biopsy | 383 | $49,207 |
| COLONOSCOPY AND BIOPSY | 193 | $43,220 |
| New patient visit (45+ min) | 836 | $37,631 |
| Return visit (30+ min) | 1,151 | $36,119 |
| Moderate sedation services provided by the same physician or other qualified health care professional performing a gastrointestinal endoscopic service that sedation supports, requiring the presence of an independent trained observer to assist in the monitoring of the patient's level of consciousness and physiological status; initial 15 minutes of intra-service time; patient age 5 years or older (additional time may be reported with 99153, as appropriate) | 889 | $30,158 |
| New patient visit (30+ min) | 206 | $13,988 |
| New patient visit (60+ min) | 135 | $7,913 |
| Service | 16 | $1,630 |
| 2024 | 4,146 | 9 | 147 | $285,458 |
| 2023 | 5,030 | 10 | 148 | $358,926 |
| 2022 | 4,259 | 10 | 101 | $286,396 |
| 2021 | 4,114 | 11 | 129 | $276,624 |
| 2020 | 2,908 | 10 | 152 | $206,934 |
| 2019 | 3,900 | 10 | 160 | $263,494 |
| 2018 | 2,406 | 11 | 94 | $95,357 |
See the largest Medicaid services in earlier years
2023
| DIAGNOSTIC COLONOSCOPY | 388 | $82,384 |
| Upper gastrointestinal endoscopy with biopsy | 427 | $62,401 |
| COLONOSCOPY AND BIOPSY | 261 | $57,981 |
| Moderate sedation services provided by the same physician or other qualified health care professional performing a gastrointestinal endoscopic service that sedation supports, requiring the presence of an independent trained observer to assist in the monitoring of the patient's level of consciousness and physiological status; initial 15 minutes of intra-service time; patient age 5 years or older (additional time may be reported with 99153, as appropriate) | 1,030 | $44,551 |
| New patient visit (45+ min) | 898 | $43,313 |
| Return visit (30+ min) | 1,205 | $34,873 |
| New patient visit (30+ min) | 274 | $16,745 |
| Short return visit (20+ min) | 485 | $9,211 |
| COLONOSCOPY W/LESION REMOVAL | 15 | $4,432 |
| New patient visit (60+ min) | 47 | $3,035 |
2022
| DIAGNOSTIC COLONOSCOPY | 306 | $63,048 |
| Upper gastrointestinal endoscopy with biopsy | 407 | $53,341 |
| COLONOSCOPY AND BIOPSY | 228 | $48,159 |
| Moderate sedation services provided by the same physician or other qualified health care professional performing a gastrointestinal endoscopic service that sedation supports, requiring the presence of an independent trained observer to assist in the monitoring of the patient's level of consciousness and physiological status; initial 15 minutes of intra-service time; patient age 5 years or older (additional time may be reported with 99153, as appropriate) | 891 | $44,499 |
| New patient visit (45+ min) | 714 | $37,200 |
| Return visit (30+ min) | 938 | $25,184 |
| Short return visit (20+ min) | 565 | $9,181 |
| New patient visit (30+ min) | 185 | $4,899 |
| New patient visit (60+ min) | 13 | $825 |
| Moderate sedation services provided by the same physician or other qualified health care professional performing the diagnostic or therapeutic service that the sedation supports, requiring the presence of an independent trained observer to assist in the monitoring of the patient's level of consciousness and physiological status; each additional 15 minutes intraservice time (List separately in addition to code for primary service) | 12 | $60 |
2021
| Upper gastrointestinal endoscopy with biopsy | 426 | $56,665 |
| DIAGNOSTIC COLONOSCOPY | 275 | $52,470 |
| COLONOSCOPY AND BIOPSY | 222 | $51,720 |
| Moderate sedation services provided by the same physician or other qualified health care professional performing a gastrointestinal endoscopic service that sedation supports, requiring the presence of an independent trained observer to assist in the monitoring of the patient's level of consciousness and physiological status; initial 15 minutes of intra-service time; patient age 5 years or older (additional time may be reported with 99153, as appropriate) | 881 | $38,621 |
| New patient visit (45+ min) | 718 | $36,479 |
| Return visit (30+ min) | 917 | $23,815 |
| Short return visit (20+ min) | 401 | $6,037 |
| New patient visit (30+ min) | 202 | $5,767 |
| COLONOSCOPY W/LESION REMOVAL | 12 | $3,020 |
| New patient visit (60+ min) | 30 | $1,819 |
| Moderate sedation services provided by the same physician or other qualified health care professional performing the diagnostic or therapeutic service that the sedation supports, requiring the presence of an independent trained observer to assist in the monitoring of the patient's level of consciousness and physiological status; each additional 15 minutes intraservice time (List separately in addition to code for primary service) | 30 | $210 |
2020
| Upper gastrointestinal endoscopy with biopsy | 348 | $43,800 |
| Moderate sedation services provided by the same physician or other qualified health care professional performing a gastrointestinal endoscopic service that sedation supports, requiring the presence of an independent trained observer to assist in the monitoring of the patient's level of consciousness and physiological status; initial 15 minutes of intra-service time; patient age 5 years or older (additional time may be reported with 99153, as appropriate) | 836 | $42,727 |
| DIAGNOSTIC COLONOSCOPY | 226 | $34,914 |
| COLONOSCOPY AND BIOPSY | 195 | $34,008 |
| New patient visit (45+ min) | 401 | $19,030 |
| Return visit (30+ min) | 574 | $16,468 |
| COLONOSCOPY W/LESION REMOVAL | 42 | $9,704 |
| New patient visit (30+ min) | 93 | $2,647 |
| Short return visit (20+ min) | 174 | $2,398 |
| New patient visit (60+ min) | 19 | $1,239 |
2019
| DIAGNOSTIC COLONOSCOPY | 256 | $53,453 |
| Upper gastrointestinal endoscopy with biopsy | 339 | $49,523 |
| COLONOSCOPY AND BIOPSY | 193 | $39,977 |
| Moderate sedation services provided by the same physician or other qualified health care professional performing a gastrointestinal endoscopic service that sedation supports, requiring the presence of an independent trained observer to assist in the monitoring of the patient's level of consciousness and physiological status; initial 15 minutes of intra-service time; patient age 5 years or older (additional time may be reported with 99153, as appropriate) | 888 | $37,020 |
| New patient visit (45+ min) | 512 | $24,249 |
| Return visit (30+ min) | 675 | $23,785 |
| New patient visit (30+ min) | 384 | $13,899 |
| Short return visit (20+ min) | 528 | $9,019 |
| COLONOSCOPY W/LESION REMOVAL | 42 | $6,942 |
| New patient visit (60+ min) | 83 | $5,627 |
2018
| New patient visit (45+ min) | 417 | $18,728 |
| Upper gastrointestinal endoscopy with biopsy | 184 | $18,011 |
| Return visit (30+ min) | 681 | $16,102 |
| COLONOSCOPY AND BIOPSY | 97 | $15,464 |
| DIAGNOSTIC COLONOSCOPY | 67 | $8,309 |
| New patient visit (30+ min) | 365 | $8,148 |
| Moderate sedation services provided by the same physician or other qualified health care professional performing a gastrointestinal endoscopic service that sedation supports, requiring the presence of an independent trained observer to assist in the monitoring of the patient's level of consciousness and physiological status; initial 15 minutes of intra-service time; patient age 5 years or older (additional time may be reported with 99153, as appropriate) | 217 | $5,053 |
| Moderate sedation services provided by the same physician or other qualified health care professional performing the diagnostic or therapeutic service that the sedation supports, requiring the presence of an independent trained observer to assist in the monitoring of the patient's level of consciousness and physiological status; initial 15 minutes of intraservice time, patient age 5 years or older | 140 | $2,865 |
| Short return visit (20+ min) | 160 | $2,261 |
| New patient visit (60+ min) | 51 | $335 |
| Moderate sedation services provided by the same physician or other qualified health care professional performing the diagnostic or therapeutic service that the sedation supports, requiring the presence of an independent trained observer to assist in the monitoring of the patient's level of consciousness and physiological status; each additional 15 minutes intraservice time (List separately in addition to code for primary service) | 27 | $83 |
Drugs they prescribed that Part D paid
$611,744
Pharmacies billed $611,744 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their Part D prescriptions (0 of 1,596) in 2024. At or below the middle of the specialty; the typical gastroenterology clinician is at 0%.
1,152 generic and fewer than 11 brand-name prescriptions · $611,744 in drug cost · 67 antibiotic prescriptions to 28 people.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Xifaxan | 38 | $111,545 | $2,935 |
| Linzess | 98 | $91,470 | $933 |
| Creon | 16 | $25,985 | $1,624 |
| Vemlidy | 17 | $23,133 | $1,361 |
| Trulance | 28 | $22,212 | $793 |
See all 23 drugs
| Xifaxan | 38 | $111,545 | $2,935 |
| Linzess | 98 | $91,470 | $933 |
| Creon | 16 | $25,985 | $1,624 |
| Vemlidy | 17 | $23,133 | $1,361 |
| Trulance | 28 | $22,212 | $793 |
| Mesalamine | 17 | $19,427 | $1,143 |
| Talicia | 13 | $10,403 | $800 |
| Gavilyte-G | 421 | $6,292 | $15 |
| Mesalamine Er | 17 | $6,115 | $360 |
| Sutab | 29 | $4,638 | $160 |
| Plenvu | 31 | $4,293 | $138 |
| Dexlansoprazole Dr | 14 | $4,220 | $301 |
| Tenofovir Disoproxil | 11 | $1,830 | $166 |
| Famotidine | 172 | $1,682 | $10 |
| Pantoprazole | 188 | $1,536 | $8 |
| Suflave | 12 | $1,467 | $122 |
| Peg-3350 and Electrolytes | 87 | $1,425 | $16 |
| Gavilyte-C | 46 | $735 | $16 |
| Dicyclomine | 34 | $562 | $17 |
| Omeprazole | 73 | $546 | $7 |
| Sulfasalazine | 11 | $200 | $18 |
| Ondansetron | 16 | $115 | $7 |
| Spironolactone | 11 | $47 | $4 |
Year by year
| 2024 | 1,596 | 846 | 0% (0) | None | $611,744 |
| 2023 | 1,260 | 564 | 0% (0) | None | $625,725 |
| 2022 | 979 | 419 | 0% (0) | 33% | $553,845 |
| 2021 | 732 | 327 | 0% (0) | 30% | $568,640 |
| 2020 | 897 | 362 | None | 26% | $613,576 |
| 2019 | 1,121 | 564 | 0% (0) | 24% | $957,460 |
| 2018 | 1,225 | 520 | 0% (0) | 30% | $1,347,183 |
| 2017 | 885 | 392 | 0% (0) | 35% | $1,035,375 |
| 2016 | 616 | 224 | None | 37% | $475,049 |
| 2015 | 288 | 122 | 0% (0) | 41% | $400,618 |
| 2014 | 100 | 49 | 0% (0) | 52% | $15,083 |
| 2013 | 297 | 257 | None | 52% | $11,933 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 20 drugs
| Xifaxan | 43 | $131,339 | $3,054 |
| Linzess | 101 | $84,657 | $838 |
| Creon | 38 | $50,799 | $1,337 |
| Trulance | 31 | $26,544 | $856 |
| Mesalamine | 14 | $16,355 | $1,168 |
| Talicia | 15 | $12,091 | $806 |
| Gavilyte-G | 236 | $3,955 | $17 |
| Pantoprazole | 194 | $3,432 | $18 |
| Sucralfate | 16 | $2,681 | $168 |
| Famotidine | 124 | $2,401 | $19 |
| Mesalamine Er | 13 | $2,329 | $179 |
| Dicyclomine | 32 | $696 | $22 |
| Omeprazole | 42 | $687 | $16 |
| Gavilyte-C | 38 | $647 | $17 |
| Peg 3350-Electrolyte | 19 | $524 | $28 |
| Peg-3350 and Electrolytes | 26 | $479 | $18 |
| Ondansetron | 17 | $303 | $18 |
| Diphenoxylate-Atropine | 12 | $244 | $20 |
| Metronidazole | 11 | $122 | $11 |
| Furosemide | 13 | $84 | $6 |
2022: 20 drugs
| Linzess | 96 | $69,598 | $725 |
| Xifaxan | 21 | $64,179 | $3,056 |
| Creon | 27 | $49,520 | $1,834 |
| Viberzi | 12 | $21,372 | $1,781 |
| Trulance | 27 | $16,620 | $616 |
| Mesalamine | 13 | $6,806 | $524 |
| Mesalamine Er | 12 | $4,846 | $404 |
| Mesalamine Dr | 11 | $3,399 | $309 |
| Sucralfate | 30 | $2,812 | $94 |
| Pantoprazole | 212 | $2,643 | $12 |
| Sutab | 15 | $2,440 | $163 |
| Gavilyte-C | 67 | $1,164 | $17 |
| Famotidine | 89 | $1,157 | $13 |
| Peg 3350-Electrolyte | 32 | $814 | $25 |
| Gavilyte-G | 48 | $668 | $14 |
| Ondansetron | 13 | $275 | $21 |
| Peg-3350 and Electrolytes | 12 | $191 | $16 |
| Omeprazole | 23 | $164 | $7 |
| Metronidazole | 11 | $126 | $11 |
| Furosemide | 11 | $35 | $3 |
2021: 19 drugs
| Humira(Cf) | 20 | $116,968 | $5,848 |
| Xifaxan | 24 | $59,556 | $2,481 |
| Creon | 25 | $48,214 | $1,929 |
| Linzess | 39 | $23,410 | $600 |
| Trulance | 11 | $6,342 | $577 |
| Dexilant | 11 | $4,862 | $442 |
| Sucralfate | 16 | $2,333 | $146 |
| Suprep | 14 | $1,527 | $109 |
| Pantoprazole | 121 | $1,380 | $11 |
| Gavilyte-C | 80 | $1,117 | $14 |
| Famotidine | 64 | $656 | $10 |
| Omeprazole | 44 | $420 | $10 |
| Peg 3350-Electrolyte | 18 | $385 | $21 |
| Clarithromycin | 13 | $374 | $29 |
| Propranolol | 14 | $233 | $17 |
| Gavilyte-G | 13 | $169 | $13 |
| Peg-3350 and Electrolytes | 13 | $157 | $12 |
| Metronidazole | 12 | $129 | $11 |
| Amoxicillin | 14 | $84 | $6 |
2020: 21 drugs
| Epclusa | 12 | $300,509 | $25,042 |
| Humira(Cf) | 18 | $103,097 | $5,728 |
| Creon | 28 | $58,059 | $2,074 |
| Linzess | 34 | $22,772 | $670 |
| Amitiza | 15 | $8,090 | $539 |
| Budesonide Ec | 28 | $7,262 | $259 |
| Mesalamine Er | 13 | $5,332 | $410 |
| Dexilant | 11 | $5,061 | $460 |
| Tenofovir Disoproxil | 15 | $4,951 | $330 |
| Pantoprazole | 179 | $1,837 | $10 |
| Ursodiol | 12 | $1,663 | $139 |
| Gavilyte-C | 109 | $1,447 | $13 |
| Esomeprazole Magnesium | 13 | $1,183 | $91 |
| Suprep | 11 | $1,162 | $106 |
| Omeprazole | 79 | $844 | $11 |
| Ondansetron | 15 | $817 | $54 |
| Cimetidine | 12 | $386 | $32 |
| Famotidine | 28 | $291 | $10 |
| Dicyclomine | 11 | $226 | $21 |
| Peg 3350-Electrolyte | 11 | $179 | $16 |
| Metronidazole | 11 | $126 | $11 |
2019: 20 drugs
| Epclusa | 15 | $378,791 | $25,253 |
| Creon | 25 | $49,732 | $1,989 |
| Xifaxan | 18 | $38,618 | $2,145 |
| Linzess | 34 | $21,065 | $620 |
| Amitiza | 15 | $9,245 | $616 |
| Dexilant | 17 | $6,072 | $357 |
| Tenofovir Disoproxil | 23 | $5,863 | $255 |
| Budesonide Ec | 14 | $5,769 | $412 |
| Gavilyte-C | 232 | $2,813 | $12 |
| Pantoprazole | 240 | $2,397 | $10 |
| Simbrinza | 12 | $2,048 | $171 |
| Hydrocortisone | 13 | $2,033 | $156 |
| Ursodiol | 12 | $1,618 | $135 |
| Omeprazole | 51 | $770 | $15 |
| Ranitidine | 71 | $677 | $10 |
| Dicyclomine | 25 | $354 | $14 |
| Sucralfate | 16 | $331 | $21 |
| Gavilyte-G | 22 | $315 | $14 |
| Peg 3350-Electrolyte | 33 | $311 | $9 |
| Gavilyte-N | 14 | $259 | $18 |
2018: 22 drugs
| Harvoni | 23 | $734,925 | $31,953 |
| Xifaxan | 30 | $62,561 | $2,085 |
| Creon | 24 | $39,929 | $1,664 |
| Amitiza | 52 | $22,307 | $429 |
| Linzess | 36 | $20,280 | $563 |
| Dexilant | 32 | $13,345 | $417 |
| Budesonide Ec | 14 | $5,984 | $427 |
| Tenofovir Disoproxil | 17 | $5,618 | $330 |
| Delzicol | 11 | $3,018 | $274 |
| Pantoprazole | 205 | $2,315 | $11 |
| Gavilyte-C | 167 | $1,972 | $12 |
| Clarithromycin | 32 | $1,332 | $42 |
| Omeprazole | 82 | $1,023 | $12 |
| Ranitidine | 98 | $762 | $8 |
| Peg 3350-Electrolyte | 58 | $586 | $10 |
| Sucralfate | 16 | $522 | $33 |
| Polyethylene Glycol 3350 | 26 | $464 | $18 |
| Lactulose | 17 | $368 | $22 |
| Amoxicillin | 34 | $275 | $8 |
| Gavilyte-N | 16 | $219 | $14 |
| Peg 3350-Electrolyte | 14 | $210 | $15 |
| Dicyclomine | 17 | $174 | $10 |
2017: 16 drugs
| Harvoni | 22 | $696,960 | $31,680 |
| Creon | 25 | $23,838 | $954 |
| Xifaxan | 13 | $22,440 | $1,726 |
| Amitiza | 54 | $21,709 | $402 |
| Viread | 17 | $19,961 | $1,174 |
| Linzess | 41 | $16,025 | $391 |
| Mesalamine | 13 | $5,058 | $389 |
| Gavilyte-C | 121 | $1,542 | $13 |
| Pantoprazole | 147 | $1,504 | $10 |
| Clarithromycin | 20 | $820 | $41 |
| Omeprazole | 42 | $763 | $18 |
| Ranitidine | 78 | $503 | $6 |
| Peg 3350-Electrolyte | 40 | $383 | $10 |
| Peg 3350-Electrolyte | 19 | $259 | $14 |
| Amoxicillin | 22 | $196 | $9 |
| Dicyclomine | 18 | $187 | $10 |
2016: 17 drugs
| Harvoni | 11 | $356,701 | $32,427 |
| Humira | 12 | $47,134 | $3,928 |
| Amitiza | 54 | $17,006 | $315 |
| Dexilant | 43 | $10,056 | $234 |
| Creon | 12 | $8,552 | $713 |
| Linzess | 21 | $7,408 | $353 |
| Pantoprazole | 108 | $1,043 | $10 |
| Gavilyte-C | 45 | $569 | $13 |
| Omeprazole | 42 | $556 | $13 |
| Clarithromycin | 15 | $517 | $34 |
| Loperamide | 14 | $494 | $35 |
| Sulfasalazine | 14 | $432 | $31 |
| Ranitidine | 53 | $358 | $7 |
| Peg 3350-Electrolyte | 14 | $236 | $17 |
| Amoxicillin | 14 | $119 | $9 |
| Peg 3350-Electrolyte | 11 | $103 | $9 |
| Dicyclomine | 11 | $87 | $8 |
2015: 8 drugs
| Delzicol | 13 | $5,043 | $388 |
| Dexilant | 23 | $5,040 | $219 |
| Amitiza | 18 | $3,741 | $208 |
| Pantoprazole | 62 | $568 | $9 |
| Peg 3350-Electrolyte | 12 | $237 | $20 |
| Peg 3350-Electrolyte | 20 | $216 | $11 |
| Omeprazole | 14 | $158 | $11 |
| Famotidine | 12 | $71 | $6 |
2014: 2 drugs
| Delzicol | 17 | $6,053 | $356 |
| Pantoprazole | 13 | $205 | $16 |
2013: 4 drugs
| Peg-3350 With Flavor Packs | 118 | $2,186 | $19 |
| Gavilyte-N | 86 | $1,556 | $18 |
| Trilyte With Flavor Packets | 15 | $277 | $18 |
| Pantoprazole | 14 | $221 | $16 |
Money from drug and device companies
$2,091 in 2025
| 2025 | 13 | 98 | None | $2,091 |
| 2024 | 13 | 83 | None | $1,395 |
| 2023 | 9 | 61 | None | $1,056 |
| 2022 | 11 | 149 | None | $2,598 |
| 2021 | 10 | 113 | None | $2,148 |
| 2020 | 8 | 84 | None | $1,615 |
| 2019 | 8 | 72 | None | $1,090 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Madrigal Pharmaceuticals | Rezdiffra | $630 | 20 payments
|
| Abbvie | Rinvoq | $429 | 24 payments
|
| Ardelyx | Ibsrela | $407 | 16 payments
|
| Salix Pharmaceuticals a division of Bausch Health US | Xifaxan | $298 | 23 payments
|
| Takeda Pharmaceuticals U.S.A. | Entyvio | $117 | 4 payments
|
| Janssen Biotech | Tremfya | $47 | 2 payments
|
See all 98 published payments
| Salix Pharmaceuticals a division of Bausch Health US | Meals · 2025-12-22 | Xifaxan | $18 |
| Takeda Pharmaceuticals U.S.A. | Meals · 2025-12-10 | Entyvio | $33 |
| Madrigal Pharmaceuticals | Meals · 2025-12-10 | Rezdiffra | $14 |
| Azurity Pharmaceuticals | Meals · 2025-12-09 | Suflave | $17 |
| Madrigal Pharmaceuticals | Meals · 2025-12-09 | Rezdiffra | $41 |
| Madrigal Pharmaceuticals | Meals · 2025-12-04 | Rezdiffra | $39 |
| Ardelyx | Meals · 2025-12-03 | Ibsrela | $23 |
| Salix Pharmaceuticals a division of Bausch Health US | Meals · 2025-12-01 | Xifaxan | $12 |
| Salix Pharmaceuticals a division of Bausch Health US | Meals · 2025-12-01 | Xifaxan | $9 |
| Ardelyx | Meals · 2025-11-27 | Ibsrela | $22 |
| Madrigal Pharmaceuticals | Meals · 2025-11-26 | Rezdiffra | $14 |
| Gilead Sciences | Meals · 2025-11-17 | None | $18 |
| QOL Medical | Meals · 2025-11-11 | Sucraid | $15 |
| Madrigal Pharmaceuticals | Meals · 2025-11-11 | Rezdiffra | $24 |
| Madrigal Pharmaceuticals | Meals · 2025-11-06 | Rezdiffra | $45 |
| Novo Nordisk | Meals · 2025-10-30 | Wegovy | $18 |
| Takeda Pharmaceuticals U.S.A. | Meals · 2025-10-30 | Entyvio | $27 |
| Salix Pharmaceuticals a division of Bausch Health US | Meals · 2025-10-30 | Xifaxan | $3 |
| Salix Pharmaceuticals a division of Bausch Health US | Meals · 2025-10-30 | Xifaxan | $8 |
| Salix Pharmaceuticals a division of Bausch Health US | Meals · 2025-10-30 | Xifaxan | $9 |
| Ardelyx | Meals · 2025-10-29 | Ibsrela | $29 |
| Abbvie | Meals · 2025-10-28 | Rinvoq | $28 |
| Madrigal Pharmaceuticals | Meals · 2025-10-23 | Rezdiffra | $21 |
| Madrigal Pharmaceuticals | Meals · 2025-10-23 | Rezdiffra | $24 |
| Salix Pharmaceuticals a division of Bausch Health US | Meals · 2025-10-20 | Xifaxan | $7 |
| Salix Pharmaceuticals a division of Bausch Health US | Meals · 2025-10-20 | Xifaxan | $17 |
| Madrigal Pharmaceuticals | Meals · 2025-10-14 | Rezdiffra | $31 |
| Ardelyx | Meals · 2025-10-13 | Ibsrela | $25 |
| Abbvie | Meals · 2025-10-09 | Skyrizi | $29 |
| Madrigal Pharmaceuticals | Meals · 2025-10-09 | Rezdiffra | $37 |
| Salix Pharmaceuticals a division of Bausch Health US | Meals · 2025-10-08 | Xifaxan | $17 |
| Abbvie | Meals · 2025-10-07 | Creon | $27 |
| Abbvie | Meals · 2025-10-07 | Rinvoq | $23 |
| Abbvie | Meals · 2025-10-07 | Rinvoq | $3 |
| Takeda Pharmaceuticals U.S.A. | Meals · 2025-09-30 | Entyvio | $34 |
| Salix Pharmaceuticals a division of Bausch Health US | Meals · 2025-09-25 | Xifaxan | $19 |
| Ardelyx | Meals · 2025-09-22 | Ibsrela | $27 |
| Braintree Laboratories | Meals · 2025-09-19 | Sutab | $16 |
| Abbvie | Meals · 2025-09-16 | Rinvoq | $25 |
| Salix Pharmaceuticals a division of Bausch Health US | Meals · 2025-09-16 | Xifaxan | $23 |
| Abbvie | Meals · 2025-09-10 | Rinvoq | $10 |
| Ardelyx | Meals · 2025-09-08 | Ibsrela | $22 |
| Abbvie | Meals · 2025-09-02 | Rinvoq | $16 |
| Ardelyx | Meals · 2025-08-25 | Ibsrela | $30 |
| Abbvie | Meals · 2025-08-19 | Viberzi | $22 |
| Abbvie | Meals · 2025-08-19 | Rinvoq | $21 |
| Abbvie | Meals · 2025-08-06 | Linzess | $11 |
| Salix Pharmaceuticals a division of Bausch Health US | Meals · 2025-08-05 | Xifaxan | $14 |
| Salix Pharmaceuticals a division of Bausch Health US | Meals · 2025-08-05 | Xifaxan | $9 |
| Ardelyx | Meals · 2025-08-05 | Ibsrela | $25 |
| Madrigal Pharmaceuticals | Meals · 2025-08-05 | Rezdiffra | $39 |
| Salix Pharmaceuticals a division of Bausch Health US | Meals · 2025-08-04 | Xifaxan | $24 |
| Abbvie | Meals · 2025-08-01 | Rinvoq | $9 |
| Ardelyx | Meals · 2025-07-24 | Ibsrela | $29 |
| Madrigal Pharmaceuticals | Meals · 2025-07-23 | Rezdiffra | $14 |
| Janssen Biotech | Meals · 2025-07-21 | Tremfya | $26 |
| Salix Pharmaceuticals a division of Bausch Health US | Meals · 2025-07-07 | Xifaxan | $17 |
| Ardelyx | Meals · 2025-07-07 | Ibsrela | $32 |
| Abbvie | Meals · 2025-07-01 | Rinvoq | $14 |
| Salix Pharmaceuticals a division of Bausch Health US | Meals · 2025-06-30 | Xifaxan | $10 |
| Salix Pharmaceuticals a division of Bausch Health US | Meals · 2025-06-30 | Xifaxan | $6 |
| Takeda Pharmaceuticals U.S.A. | Meals · 2025-06-25 | Entyvio | $24 |
| Madrigal Pharmaceuticals | Meals · 2025-06-25 | Rezdiffra | $12 |
| Ardelyx | Meals · 2025-06-18 | Ibsrela | $17 |
| Madrigal Pharmaceuticals | Meals · 2025-06-17 | Rezdiffra | $35 |
| Madrigal Pharmaceuticals | Meals · 2025-06-12 | Rezdiffra | $42 |
| Ardelyx | Meals · 2025-06-11 | Ibsrela | $19 |
| Abbvie | Meals · 2025-06-10 | Skyrizi | $11 |
| Madrigal Pharmaceuticals | Meals · 2025-06-10 | Rezdiffra | $42 |
| Ardelyx | Meals · 2025-05-28 | Ibsrela | $29 |
| Abbvie | Meals · 2025-05-22 | Rinvoq | $23 |
| Abbvie | Meals · 2025-05-21 | Rinvoq | $20 |
| Madrigal Pharmaceuticals | Meals · 2025-05-15 | Rezdiffra | $40 |
| Salix Pharmaceuticals a division of Bausch Health US | Meals · 2025-04-28 | Xifaxan | $18 |
| Salix Pharmaceuticals a division of Bausch Health US | Meals · 2025-04-28 | Xifaxan | $15 |
| Salix Pharmaceuticals a division of Bausch Health US | Meals · 2025-04-28 | Xifaxan | $7 |
| Abbvie | Meals · 2025-04-25 | Skyrizi | $16 |
| Ardelyx | Meals · 2025-04-11 | Ibsrela | $23 |
| Madrigal Pharmaceuticals | Meals · 2025-04-10 | Rezdiffra | $39 |
| Abbvie | Meals · 2025-04-09 | Rinvoq | $17 |
| Gilead Sciences | Meals · 2025-04-08 | None | $18 |
| Celltrion USA | Meals · 2025-04-07 | Vegzelma | $15 |
| Madrigal Pharmaceuticals | Meals · 2025-03-18 | Rezdiffra | $41 |
| Pfizer | Meals · 2025-03-17 | Xeljanz | $21 |
| Madrigal Pharmaceuticals | Meals · 2025-03-06 | Rezdiffra | $38 |
| Abbvie | Meals · 2025-03-04 | Creon | $22 |
| Abbvie | Meals · 2025-03-04 | Rinvoq | $16 |
| Abbvie | Meals · 2025-03-04 | Skyrizi | $20 |
| Salix Pharmaceuticals a division of Bausch Health US | Meals · 2025-02-28 | Xifaxan | $3 |
| Salix Pharmaceuticals a division of Bausch Health US | Meals · 2025-02-28 | Xifaxan | $12 |
| Pfizer | Meals · 2025-02-24 | Xeljanz | $24 |
| Abbvie | Meals · 2025-02-21 | Skyrizi | $18 |
| Salix Pharmaceuticals a division of Bausch Health US | Meals · 2025-02-05 | Xifaxan | $17 |
| Abbvie | Meals · 2025-01-27 | Skyrizi | $14 |
| Abbvie | Meals · 2025-01-24 | Rinvoq | $14 |
| Ardelyx | Meals · 2025-01-24 | Ibsrela | $28 |
| Janssen Biotech | Meals · 2025-01-22 | Tremfya | $21 |
| Ardelyx | Meals · 2025-01-10 | Ibsrela | $28 |
See earlier years (2024, 2023, 2022, 2021, 2020, 2019)
2024: $1,395
| Salix Pharmaceuticals a division of Bausch Health US | Xifaxan | $497 | 32 payments
|
| Abbvie | Rinvoq | $340 | 24 payments
|
| Pfizer | Xeljanz | $165 | 8 payments
|
| Madrigal Pharmaceuticals | Resmetirom | $148 | 6 payments
|
| Gilead Sciences | None | $68 | 3 payments
|
| Takeda Pharmaceuticals U.S.A. | Entyvio | $41 | 2 payments
|
| Braintree Laboratories | Sutab | $31 | 2 payments
|
| RedHill Biopharma | Talicia | $23 | 1 payment
|
| Phathom Pharmaceuticals | Voquezna | $21 | 1 payment
|
| Intercept Pharmaceuticals | Ocaliva | $17 | 1 payment
|
| Celltrion USA | Vegzelma | $16 | 1 payment
|
| Janssen Biotech | Tremfya | $14 | 1 payment
|
| Ardelyx | Ibsrela | $13 | 1 payment
|
2023: $1,056
| Salix Pharmaceuticals a division of Bausch Health US | Xifaxan | $376 | 19 payments
|
| AbbVie | Mavyret | $309 | 20 payments
|
| RedHill Biopharma | Talicia | $133 | 10 payments
|
| Gilead Sciences | None | $68 | 3 payments
|
| Ardelyx | Ibsrela | $53 | 3 payments
|
| Celgene | Zeposia | $34 | 2 payments
|
| Intercept Pharmaceuticals | Ocaliva | $33 | 2 payments
|
| Boston Scientific | None | $30 | 1 payment
|
| Takeda Pharmaceuticals U.S.A. | Entyvio | $21 | 1 payment
|
2022: $2,598
| Salix Pharmaceuticals a division of Bausch Health US | Xifaxan | $1,024 | 51 payments
|
| Abbvie | Humira | $834 | 53 payments
|
| RedHill Biopharma | Talicia | $206 | 13 payments
|
| Celgene | Zeposia | $173 | 18 payments
|
| Gilead Sciences | None | $117 | 5 payments
|
| PENTAX of America | C2 Cryoballoon | $62 | 1 payment
|
| Intercept Pharmaceuticals | Ocaliva | $56 | 3 payments
|
| Pfizer | Xeljanz | $49 | 2 payments
|
| Genzyme | Dupixent | $32 | 1 payment
|
| Takeda Pharmaceuticals U.S.A. | Entyvio | $28 | 1 payment
|
| Merck Sharp & Dohme | Dificid | $16 | 1 payment
|
2021: $2,148
| AbbVie | Humira | $867 | 48 payments
|
| Salix Pharmaceuticals a division of Bausch Health US | Xifaxan | $818 | 42 payments
|
| Gilead Sciences | None | $248 | 12 payments
|
| Intercept Pharmaceuticals | Ocaliva | $58 | 3 payments
|
| Merck Sharp & Dohme | Dificid | $40 | 2 payments
|
| RedHill Biopharma | Movantik | $39 | 2 payments
|
| Takeda Pharmaceuticals U.S.A. | Entyvio | $23 | 1 payment
|
| Evoke Pharma | Gimoti | $22 | 1 payment
|
| Boston Scientific | Cre | $19 | 1 payment
|
| Celgene | Zeposia | $13 | 1 payment
|
2020: $1,615
| Salix Pharmaceuticals a division of Bausch Health US | Xifaxan | $792 | 44 payments
|
| AbbVie | Humira | $423 | 20 payments
|
| Gilead Sciences | None | $138 | 5 payments
|
| RedHill Biopharma | Talicia | $133 | 8 payments
|
| Intercept Pharmaceuticals | Ocaliva | $45 | 2 payments
|
| Merck Sharp & Dohme | Dificid | $31 | 2 payments
|
| Allergan | Linzess | $31 | 2 payments
|
| Daiichi Sankyo | Injectafer | $22 | 1 payment
|
2019: $1,090
| Salix Pharmaceuticals a division of Bausch Health US | Xifaxan | $324 | 18 payments
|
| AbbVie | Creon | $243 | 13 payments
|
| Gilead Sciences | None | $183 | 14 payments
|
| Allergan | Linzess | $173 | 18 payments
|
| Takeda Pharmaceuticals U.S.A. | Entyvio | $67 | 5 payments
|
| Braintree Laboratories | Suprep Bowel Prep | $53 | 1 payment
|
| QOL Medical | Sucraid | $27 | 2 payments
|
| Shionogi | Mulpleta | $19 | 1 payment
|
Research money
Money a company paid to run a study. Where it went to their institution, the clinician is named as an investigator and did not receive it; the amount covers the whole study, often across many sites.
| PFIZER INC. · A Phase 2b Multicenter Randomized Doubleblind Placebocontrolled Doseranging Study To Evaluate the Efficacy Safety and Pharmacokinetics of Pf06480605 in Adult Participants With Moderate To Severe Ulcerative Colitis · 2021 | Their institution | $3,450 |
Professional record
- NPI
- 1952322984
- Licence
- CA A78604California A78604: Current · expires 2028-04-30
- Trained
- Wake Forest University School of Medicine, 1996 · 30 years ago
- Gender
- Male
More record details
- Sole proprietor
- No
- Taxonomy
- Federal specialty code 174400000X (174400000X)
- Mailing address
- 8110 Airport Blvd, Los Angeles, CA, 90045
- NPI first listed
- 2006-07-23
- NPI last updated
- 2007-07-08
This is when the NPI record was last certified, not a medical board exam.